1. Home
  2. LUCD vs TBB Comparison

LUCD vs TBB Comparison

Compare LUCD & TBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCD
  • TBB
  • Stock Information
  • Founded
  • LUCD 2018
  • TBB N/A
  • Country
  • LUCD United States
  • TBB United States
  • Employees
  • LUCD 70
  • TBB 140990
  • Industry
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TBB Telecommunications Equipment
  • Sector
  • LUCD Health Care
  • TBB Telecommunications
  • Exchange
  • LUCD Nasdaq
  • TBB Nasdaq
  • Market Cap
  • LUCD 135.6M
  • TBB N/A
  • IPO Year
  • LUCD 2021
  • TBB 2017
  • Fundamental
  • Price
  • LUCD $1.15
  • TBB $22.58
  • Analyst Decision
  • LUCD Strong Buy
  • TBB
  • Analyst Count
  • LUCD 4
  • TBB 0
  • Target Price
  • LUCD $3.88
  • TBB N/A
  • AVG Volume (30 Days)
  • LUCD 1.3M
  • TBB N/A
  • Earning Date
  • LUCD 05-14-2025
  • TBB N/A
  • Dividend Yield
  • LUCD N/A
  • TBB N/A
  • EPS Growth
  • LUCD N/A
  • TBB N/A
  • EPS
  • LUCD N/A
  • TBB N/A
  • Revenue
  • LUCD $4,346,000.00
  • TBB N/A
  • Revenue This Year
  • LUCD $107.75
  • TBB N/A
  • Revenue Next Year
  • LUCD $231.37
  • TBB N/A
  • P/E Ratio
  • LUCD N/A
  • TBB N/A
  • Revenue Growth
  • LUCD 79.00
  • TBB N/A
  • 52 Week Low
  • LUCD $0.63
  • TBB N/A
  • 52 Week High
  • LUCD $1.80
  • TBB N/A
  • Technical
  • Relative Strength Index (RSI)
  • LUCD 41.93
  • TBB 44.91
  • Support Level
  • LUCD $1.19
  • TBB $22.56
  • Resistance Level
  • LUCD $1.24
  • TBB $22.84
  • Average True Range (ATR)
  • LUCD 0.07
  • TBB 0.21
  • MACD
  • LUCD -0.00
  • TBB 0.02
  • Stochastic Oscillator
  • LUCD 15.79
  • TBB 34.48

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About TBB AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The firm is the third-largest US wireless carrier, connecting 72 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 15% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 11% of revenue, primarily consist of broadband internet access, serving 14 million customers. AT&T also has a sizable presence in Mexico, with 23 million customers, but this business only accounts for 4% of revenue. The firm recently agreed to sell its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.

Share on Social Networks: